GSK has higher 2006 tax bill
GlaxoSmithKline has reported a number of unresolved tax issues around the world at the same time as its effective tax rate edged up in 2006.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: